Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.3%

1 terminated/withdrawn out of 43 trials

Success Rate

96.0%

+9.5% vs industry average

Late-Stage Pipeline

26%

11 trials in Phase 3/4

Results Transparency

0 of 24 completed trials have results

Key Signals

8 recruiting

Enrollment Performance

Analytics

N/A

18(48.6%)

Phase 4

9(24.3%)

Phase 1

5(13.5%)

Phase 3

2(5.4%)

Phase 2

2(5.4%)

Early Phase 1

1(2.7%)

37Total

N/A(18)

Phase 4(9)

Phase 1(5)

Phase 3(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (43)

Showing 20 of 43 trials

NCT07526870Not ApplicableCompleted

Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement

Role: lead

NCT07471997Not ApplicableCompleted

Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease

Role: lead

NCT07458126Completed

Digital Colorimetric Scale for Recurrent Pterygium Scar Assessment

Role: lead

NCT07451678Phase 4Completed

Treatment of Blepharitis Induced by Demodex Folliculorum Through Eyelid Cleansing With Wipes Containing Topical Chlorhexidine

Role: lead

NCT07397520Phase 4Recruiting

The Application of Intralesional 5-fluorouracil for the Management of Hypertrophic Facial Scars in the Periocular Region Resulting From Trauma and Surgical Procedures in Individuals Aged Over 18 Years

Role: lead

NCT07401342Phase 4Completed

An Assessment of the Efficacy and Safety of Employing a Duosomal Chemical Peel for Aesthetic Enhancement in the Periocular and Facial Regions

Role: lead

NCT07385495Active Not Recruiting

OJO-miR: microRNA Expression in Allergic Conjunctivitis.

Role: lead

NCT07387536Phase 4Recruiting

The Effectiveness of Topical Silicone Application Combined With Photoprotection in the Development of Scarring Following Blepharoplasty

Role: lead

NCT07376148Phase 4Recruiting

Fractional CO2 Laser-assisted Delivery of Hyaluronic Acid, Ascorbic Acid and Sodium DNA For Enhancing Facial Skin Quality in Individuals Over the Age of 30

Role: lead

NCT07372911Not ApplicableRecruiting

PRoTECT: Corneal Wavefront Guided PRK + Epi-off CXL vs. PTK+Epi-off CXL in Keratoconus

Role: lead

NCT07372014Phase 4Active Not Recruiting

A Comparative Analysis of the Effectiveness of Nepafenac Combined With a Lubricant Versus a Lubricant Alone in the Treatment of Epiphora Associated With Lacrimal Punctum Stenosis

Role: lead

NCT07372001Phase 4Completed

Effects on Facial Skin Aging After Topical Application of Exosomes With a Microneedling Device

Role: lead

NCT07178600Recruiting

Clinical Determinants and Adverse Reactions to Tropicamide/Phenylephrine in Hospitalized Patients.

Role: lead

NCT07171307Not Yet Recruiting

Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy

Role: lead

NCT07149298Active Not Recruiting

Quality of Life In Patients With Allergic Conjunctivitis In Treatment With Sublingual Allergen Immunotherapy In A Referral Ophthalmological Hospital

Role: lead

NCT06477081Not ApplicableRecruiting

KLEx Versus FS-LASIK for the Treatment of Myopia and Compound Myopic Astigmatism

Role: lead

NCT06219252Not ApplicableRecruiting

Intraoperative Aberrometry vs Conventional Intraocular Lens Calculation, a Prospective Study.

Role: lead

NCT06931041Phase 3Active Not Recruiting

Comparing Efficacy of Autologous Serum Eye Drops With and Without Insulin in Autoimmune Dry Eye: A Randomized Clinical Trial

Role: lead

NCT06428266Not ApplicableCompleted

Closed Dacryointubation vs Bicanalicular Intubation for Proximal Tear Duct Obstruction

Role: lead

NCT06402643Not ApplicableRecruiting

Comparison of Recurrence Between Mini-SLET and Limbal-Conjunctival Autograft Techniques in Primary Pterygium

Role: lead